Literature DB >> 18834607

A hantavirus causing hemorrhagic fever with renal syndrome requires gC1qR/p32 for efficient cell binding and infection.

Yun Choi1, Young-Chan Kwon, Soo-In Kim, Jung-Min Park, Kyung-Hee Lee, Byung-Yoon Ahn.   

Abstract

Hantaan virus (HTNV) is a pathogenic hantavirus that causes hemorrhagic fever with renal syndrome (HFRS). HTNV infection is mediated by alpha v beta3 integrin. We used protein blots of Vero E6 cell homogenates to demonstrate that radiolabeled HTNV virions bind to gC1qR/p32, the acidic 32-kDa protein known as the receptor for the globular head domain of complement C1q. RNAi-mediated suppression of gC1qR/p32 markedly reduced HTNV binding and infection in human lung epithelial A549 cells. Conversely, transient expression of either simian or human gC1qR/p32 rendered non-permissive CHO cells susceptible to HTNV infection. These results suggest an important role for gC1qR/p32 in HTNV infection and pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18834607     DOI: 10.1016/j.virol.2008.08.035

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

Review 1.  Uncovering the mysteries of hantavirus infections.

Authors:  Antti Vaheri; Tomas Strandin; Jussi Hepojoki; Tarja Sironen; Heikki Henttonen; Satu Mäkelä; Jukka Mustonen
Journal:  Nat Rev Microbiol       Date:  2013-08       Impact factor: 60.633

2.  Cell-surface receptor for complement component C1q (gC1qR) is a key regulator for lamellipodia formation and cancer metastasis.

Authors:  Ki-Bum Kim; Jae-Sung Yi; Nga Nguyen; Joo-Hyung Lee; Young-Chan Kwon; Byung-Yoon Ahn; Hana Cho; Yoon Ki Kim; Hee-Jung Yoo; Jae-Seon Lee; Young-Gyu Ko
Journal:  J Biol Chem       Date:  2011-05-02       Impact factor: 5.157

3.  Binding of cellular p32 protein to the rubella virus P150 replicase protein via PxxPxR motifs.

Authors:  Suganthi Suppiah; Heather A Mousa; Wen-Pin Tzeng; Jason D Matthews; Teryl K Frey
Journal:  J Gen Virol       Date:  2012-01-13       Impact factor: 3.891

4.  Hantavirus entry: Perspectives and recent advances.

Authors:  Eva Mittler; Maria Eugenia Dieterle; Lara M Kleinfelter; Megan M Slough; Kartik Chandran; Rohit K Jangra
Journal:  Adv Virus Res       Date:  2019-08-07       Impact factor: 9.937

Review 5.  An approach to p32/gC1qR/HABP1: a multifunctional protein with an essential role in cancer.

Authors:  Carlos Alejandro Egusquiza-Alvarez; Martha Robles-Flores
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-20       Impact factor: 4.322

6.  HIV gp41 engages gC1qR on CD4+ T cells to induce the expression of an NK ligand through the PIP3/H2O2 pathway.

Authors:  Hugues Fausther-Bovendo; Vincent Vieillard; Sandrine Sagan; Georges Bismuth; Patrice Debré
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

7.  Identification of the gC1qR sites for the HIV-1 viral envelope protein gp41 and the HCV core protein: Implications in viral-specific pathogenesis and therapy.

Authors:  Lina Pednekar; Alisa Valentino; Yan Ji; Nithin Tumma; Christopher Valentino; Adarsh Kadoor; Kinga K Hosszu; Mahalakshmi Ramadass; Richard R Kew; Uday Kishore; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Mol Immunol       Date:  2016-04-23       Impact factor: 4.407

8.  Dobrava-Belgrade hantavirus from Germany shows receptor usage and innate immunity induction consistent with the pathogenicity of the virus in humans.

Authors:  Elena Popugaeva; Peter T Witkowski; Mathias Schlegel; Rainer G Ulrich; Brita Auste; Andreas Rang; Detlev H Krüger; Boris Klempa
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

9.  Hantaviruses in the americas and their role as emerging pathogens.

Authors:  Brian Hjelle; Fernando Torres-Pérez
Journal:  Viruses       Date:  2010-11-25       Impact factor: 5.048

10.  Haploid Genetic Screen Reveals a Profound and Direct Dependence on Cholesterol for Hantavirus Membrane Fusion.

Authors:  Lara M Kleinfelter; Rohit K Jangra; Lucas T Jae; Andrew S Herbert; Eva Mittler; Katie M Stiles; Ariel S Wirchnianski; Margaret Kielian; Thijn R Brummelkamp; John M Dye; Kartik Chandran
Journal:  MBio       Date:  2015-06-30       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.